• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    90 Biggest Movers From Yesterday

    5/13/22 5:44:49 AM ET
    $ABVC
    $ACXP
    $AFI
    $AFRM
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ABVC alert in real time by email

    Gainers

    • Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.
    • Squarespace, Inc. (NYSE:SQSP) jumped 48.5% to close at $21.44 after the company reported better-than-expected Q1 sales results and issued Q2 and FY22 sales guidance above analyst estimates. The company also announced a buyback program of up to $200 million.
    • Lordstown Motors Corp. (NASDAQ:RIDE) jumped 47% to close at $2.22. Lordstown Motors completed a deal to sell certain assets to Foxconn.
    • Jupai Holdings Limited (NYSE:JP) gained 44% to settle at $0.75.
    • Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) jumped 38.8% to close at $0.2220. Salarius Pharmaceuticals successfully completed the pre-IND meeting process with the FDA for SP-3164 in hematological cancers and solid tumors.
    • MoneyLion Inc. (NYSE:ML) gained 35.5% to settle at $1.64 after the company reported better-than-expected Q1 EPS and sales results. The company reaffirmed FY22 guidance.
    • Diebold Nixdorf, Incorporated (NYSE:DBD) gained 35.1% to settle at $3.08. Diebold Nixdorf recently reported worse-than-expected Q1 results and cut FY22 guidance.
    • AppLovin Corporation (NASDAQ:APP) shares climbed 34.7% to close at $36.74 after the company reported better-than-expected Q1 sales results and announced a $750 million share buyback.
    • Kubient, Inc. (NASDAQ:KBNT) gained 34.5% to settle at $0.9976.
    • SunOpta Inc. (NASDAQ:STKL) climbed 31.7% to close at $6.44 following upbeat quarterly earnings.
    • Stealth BioTherapeutics Corp (NASDAQ:MITO) gained 31.5% to close at $0.25 after the company announced the FDA has granted Orphan Drug Designation for elamipretide for the treatment duchenne muscular dystrophy.
    • Bakkt Holdings, Inc. (NASDAQ:BKKT) shares jumped 30.2% to close at $2.80 after dipping 19% on Wednesday.
    • SQL Technologies Corp. (NASDAQ:SKYX) rose 30% to close at $4.85.
    • Bumble Inc. (NASDAQ:BMBL) gained 26.8% to close at $22.36 after the company reported better-than-expected Q1 EPS and sales results.
    • Purple Innovation, Inc. (NASDAQ:PRPL) rose 25.4% to settle at $4.10. Purple Innovation reported better-than-expected Q1 EPS and sales results.
    • Compass Therapeutics, Inc. (NASDAQ:CMPX) gained 25% to close at $2.30. Compass Therapeutics recently posted a Q1 loss of $0.07 per share.
    • Carvana Co. (NYSE:CVNA) climbed 24.7% to close at $37.40. Stifel recently downgraded Carvana from Buy to Hold and lowered the price target from $115 to $40.
    • Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) gained 24.6% to close at $3.45. Concert Pharmaceuticals recently posted a Q1 loss of $1.03 per share.
    • 89bio, Inc. (NASDAQ:ETNB) surged 24.2% to close at $2.67 following Q1 earnings.
    • SciSparc Ltd. (NASDAQ:SPRC) rose 23.4% to settle at $2.90.
    • Affirm Holdings, Inc. (NASDAQ:AFRM) gained 23.3% to settle at $18.04. Affirm reported better-than-expected Q3 EPS and sales results after the closing bell.
    • Cullinan Oncology, Inc. (NASDAQ:CGEM) rose 23.1% to close at $9.00 after the company and Taiho Pharmaceutical announced a strategic collaboration to jointly develop and commercialize CLN-081/TAS6417 and Taiho's acquisition of Cullinan Pearl.
    • Caribou Biosciences, Inc. (NASDAQ:CRBU) gained 22.2% to close at $8.10. Caribou Biosciences announced initial data for CB-010 anti-CD19 allogeneic CAR-T cell therapy to be presented at EHA 2022 Hybrid Congress Jun. 9-17.
    • Ontrak, Inc. (NASDAQ:OTRK) jumped 21.8% to settle at $1.34 following Q1 results.
    • Rail Vision Ltd. (NASDAQ:RVSN) rose 21.8% to close at $1.34. Knorr-Bremse Systeme für Schienenfahrzeuge reported in 13D Filing a new stake of 36.8% in Rail Vision.
    • ViewRay, Inc. (NASDAQ:VRAY) gained 21.6% to close at $2.98.
    • Redfin Corporation (NASDAQ:RDFN) rose 21.3% to settle at $10.69.
    • Sharecare, Inc. (NASDAQ:SHCR) surged 20.4% to close at $2.36 after the company reported better-than-expected Q1 EPS and sales results, issued Q2 and FY22 guidance and reported a $50 million buyback.
    • Traeger, Inc. (NYSE:COOK) gained 20% to close at $5.29 after the company reported better-than-expected Q1 EPS and sales results and issued guidance.
    • AlloVir, Inc. (NASDAQ:ALVR) jumped 19.9% to close at $3.91.
    • EVgo, Inc. (NASDAQ:EVGO) rose 19.7% to settle at $8.58 after Credit Suisse upgraded the stock from Neutral to Outperform and announced a $14 price target.
    • Berkeley Lights, Inc. (NASDAQ:BLI) jumped 19.5% to close at $4.50. Berkeley Lights recently posted a Q1 loss of $0.32 per share.
    • Roblox Corporation (NYSE:RBLX) gained 19.2% to close at $28.58. Roblox recently reported worse-than-expected Q1 EPS and sales results.
    • Ondas Holdings Inc. (NASDAQ:ONDS) jumped 19.1% to settle at $6.04. Ondas Holdings recently posted Q1 loss of $0.24 per share.
    • Vapotherm, Inc. (NYSE:VAPO) gained 19% to close at $3.44.
    • Marqeta, Inc. (NASDAQ:MQ) rose 18.9% to settle at $7.88 after the company reported better-than-expected Q1 sales results and issued Q2 sales growth guidance.
    • The Very Good Food Company Inc. (NASDAQ:VGFC) rose 18.8% to close at $0.25.
    • Coupang, Inc. (NYSE:CPNG) shares climbed 18.5% to settle at $11.46 after the company reported better-than-expected Q1 EPS results.
    • Rivian Automotive, Inc. (NASDAQ:RIVN) gained 18% to close at $24.30 after the company reported better-than-expected Q1 EPS results.
    • Rekor Systems, Inc. (NASDAQ:REKR) gained 17.2% to close at $2.59.
    • Unity Software Inc. (NYSE:U) gained 15.8% to close at $35.09. Unity Software recently reported worse-than-expected Q1 sales results and issued Q2 and FY22 sales guidance below analyst estimates.
    • Olo Inc. (NYSE:OLO) climbed 15.7% to settle at $11.21. Olo posted Q1 adjusted EPS of $0.01.
    • Sierra Wireless, Inc. (NASDAQ:SWIR) surged 15.2% to close at $18.79 following strong Q1 earnings.
    • DarioHealth Corp. (NASDAQ:DRIO) rose 13.4% to close at $5.18 following strong Q1 results.
    • Omeros Corporation (NASDAQ:OMER) climbed 13% to close at $2.95. The company recent posted upbeat quarterly earnings.
    • Groupon, Inc. (NASDAQ:GRPN) jumped 11.8% to close at $14.23. Groupon 10% owner Pale Fire Capital SE acquired a total of 1,651,277 shares at an average price of $14.31.
    • GameStop Corp. (NYSE:GME) rose 10.1% to close at $89.57.
    • Enovix Corporation (NASDAQ:ENVX) rose 9.6% to close at $8.23 after the company posted Q1 earnings.
    • ClearPoint Neuro, Inc. (NASDAQ:CLPT) gained 9.2% to close at $7.74 after the company reported better-than-expected Q1 EPS and sales results and issued FY22 revenue guidance above analyst estimates.
    • STMicroelectronics N.V. (NYSE:STM) rose 5.6% to close at $37.02. STMicroelectronics said it sees over $20 billion in annual sales by 2027.


    Losers

    • Tenon Medical, Inc. (NASDAQ:TNON) shares tumbled 75.7% to settle at $8.86 on Thursday.
    • Atento S.A. (NYSE:ATTO) shares fell 36.1% to close at $14.93 on Thursday after reporting Q1 results.
    • AppTech Payments Corp. (NASDAQ:APCX) declined 34.8% to close at $0.8086. AppTech Payments recently reported Q1 sales of $104,000.
    • Rockwell Medical, Inc. (NASDAQ:RMTI) dropped 32.5% to close at $0.2158 after the company announced a 1-for-11 reverse stock split, effective May 13, 2022.
    • Eve Holding Inc. (NYSE:EVEX) fell 31.3% to close at $6.44.
    • MOGU Inc. (NYSE:MOGU) dropped 28.3% to close at $1.44.
    • Chicken Soup for the Soul Entertainment, Inc. (NASDAQ:CSSE) fell 27% to close at $5.21. Chicken Soup For The Soul Entertainment agreed to acquire entertainment company Redbox Entertainment.
    • Dutch Bros Inc. (NYSE:BROS) shares fell 26.9% to close at $25.11 after the company reported worse-than-expected Q1 EPS results and issued FY22 revenue guidance below analyst estimates.
    • Marpai, Inc. (NASDAQ:MRAI) fell 26.7% to close at $0.9239 after the company reported Q1 earnings results.
    • Applied Blockchain, Inc. (NASDAQ:APLD) fell 26.5% to close at $1.80.
    • Intellicheck, Inc. (NASDAQ:IDN) fell 26.3% to settle at $1.43 after the company postponed its Q1 earnings report.
    • Eargo, Inc. (NASDAQ:EAR) declined 24.7% to close at $1.28 after the company announced its inability to file the Q1 2022 Form 10-Q on a timely basis and said Nasdaq may take additional actions as a result.
    • Helius Medical Technologies, Inc. (NASDAQ:HSDT) dropped 23.7% to close at $1.48 following weak quarterly earnings.
    • Mogo Inc. (NASDAQ:MOGO) fell 23.5% to settle at $1.04 following Q1 results.
    • Pulse Biosciences, Inc. (NASDAQ:PLSE) dropped 23.3% to close at $1.48 following weak quarterly results.
    • iClick Interactive Asia Group Limited (NASDAQ:ICLK) fell 23.1% to close at $0.6290.
    • Cidara Therapeutics, Inc. (NASDAQ:CDTX) declined 22.7% to close at $0.46. Cidara Therapeutics posted a Q1 loss of $0.27 per share.
    • Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) fell 22.3% to close at $2.61. Acurx Pharmaceuticals posted Q1 2022 R&D expenses of $800K.
    • Digital Media Solutions, Inc. (NYSE:DMS) fell 21.8% to close at $1.40.
    • Outbrain Inc. (NASDAQ:OB) dipped 20.4% to close at $6.28 after reporting Q1 results.
    • iMedia Brands, Inc. (NASDAQ:IMBI) fell 20.1% to close at $2.35 after the company announced pricing of $24 million registered direct offering.
    • AcuityAds Holdings Inc. (NASDAQ:ATY) fell 19.1% to close at $1.86. AcuityAds Holdings posted a Q1 loss of $0.07 per share.
    • FingerMotion, Inc. (NASDAQ:FNGR) declined 18.9% to settle at $1.24.
    • Armstrong Flooring, Inc. (NYSE:AFI) shares declined 18.4% to close at $0.3998. Armstrong Flooring shares jumped 237% on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company.
    • Societal CDMO, Inc. (NASDAQ:SCTL) fell 18% to close at $0.9999 following Q1 results.
    • Usio, Inc. (NASDAQ:USIO) fell 17.6% to close at $1.99 following wider-than-expected quarterly loss.
    • Rockley Photonics Holdings Limited (NYSE:RKLY) fell 16.8% to close at $2.33 after the company reported Q1 results and announced a $81.5 million private placement.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) fell 16.3% to settle at $2.68. Chicken Soup For The Soul Entertainment Inc (NASDAQ:CSSE) agreed to acquire entertainment company Redbox Entertainment.
    • Mawson Infrastructure Group, Inc. (NASDAQ:MIGI) dropped 16.2% to close at $2.43 as the company issued April 2022 bitcoin self-mining, hosting co-location and operational update.
    • ABVC BioPharma, Inc. (NASDAQ:ABVC) dipped 13.8% to close at $2.12 after announcing a $4.22 million registered direct offering.
    • Docebo Inc. (NASDAQ:DCBO) declined 13.2% to close at $29.72 after reporting a wider quarterly loss.
    • Verb Technology Company, Inc. (NASDAQ:VERB) fell 11.8% to close at $0.3014 after declining 32% on Wednesday.
    • Fluence Energy, Inc. (NASDAQ:FLNC) fell 11% to close at $6.31.
    • Manulife Financial Corporation (NYSE:MFC) fell 10.5% to close at $16.76 after the company reported Q1 earnings results.
    • The Vita Coco Company, Inc. (NASDAQ:COCO) dropped 9.1% to close at $9.08 following Q1 results.
    • WaveDancer, Inc. (NASDAQ:WAVD) declined 8% to close at $2.8797.
    • Regulus Therapeutics Inc. (NASDAQ:RGLS) fell 7.7% to close at $0.2456. Regulus Therapeutics shares jumped around 55% on Wednesday after the company announced the FDA has accepted its Investigational New Drug Application for RGLS8429 for the treatment of Autosomal Dominant Polycystic Kidney Disease.
    • Pear Therapeutics, Inc. (NASDAQ:PEAR) fell 6.5% to close at $3.60. Pear Therapeutics announced inclusion of QuickMD in its telehealth provider experience initiative.
    • Eneti Inc. (NYSE:NETI) slipped 5.5% to close at $5.63 following Q1 results.
    • Fossil Group, Inc. (NASDAQ:FOSL) declined 5% to close at $7.61 after the company reported worse-than-expected Q1 sales results and adjusted EPS results were lower year over year. The company also cut FY22 net sales guidance.
    Get the next $ABVC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABVC
    $ACXP
    $AFI
    $AFRM

    CompanyDatePrice TargetRatingAnalyst
    Enovix Corporation
    $ENVX
    2/26/2026$15.00 → $7.50Hold
    TD Cowen
    Affirm Holdings Inc.
    $AFRM
    2/20/2026$55.00Neutral
    Robert W. Baird
    Fossil Group Inc.
    $FOSL
    2/19/2026$7.00Outperform
    Northland Capital
    Cullinan Therapeutics Inc.
    $CGEM
    2/17/2026$33.00Buy
    Citigroup
    Marqeta Inc.
    $MQ
    2/17/2026$6.00Overweight
    Analyst
    Rivian Automotive Inc.
    $RIVN
    2/17/2026$14.00Neutral → Underperform
    DA Davidson
    Rivian Automotive Inc.
    $RIVN
    2/13/2026$23.00Hold → Buy
    Deutsche Bank
    Compass Therapeutics Inc.
    $CMPX
    2/13/2026$15.00Buy
    Craig Hallum
    More analyst ratings

    $ABVC
    $ACXP
    $AFI
    $AFRM
    SEC Filings

    View All

    Pulse Biosciences Inc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - PULSE BIOSCIENCES, INC. (0001625101) (Filer)

    2/27/26 5:26:13 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    SEC Form PREM14A filed by SunOpta Inc.

    PREM14A - SunOpta Inc. (0000351834) (Filer)

    2/27/26 5:19:02 PM ET
    $STKL
    Farming/Seeds/Milling
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Marpai Inc.

    SCHEDULE 13G/A - Marpai, Inc. (0001844392) (Subject)

    2/27/26 10:13:31 AM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    $ABVC
    $ACXP
    $AFI
    $AFRM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Derosa Thomas Joseph bought $6,754 worth of shares (20,000 units at $0.34), increasing direct ownership by 77% to 46,096 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    2/27/26 6:16:02 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    General Counsel and Secretary D'Annunzio Marc sold $7,924 worth of shares (785 units at $10.09), decreasing direct ownership by 0.66% to 117,833 units (SEC Form 4)

    4 - Bakkt, Inc. (0001820302) (Issuer)

    2/27/26 5:49:38 PM ET
    $BKKT
    Finance: Consumer Services
    Finance

    SVP, Chief Financial Officer Yahes Jarrod sold $220,382 worth of shares (12,196 units at $18.07), decreasing direct ownership by 2% to 533,933 units (SEC Form 4)

    4 - Unity Software Inc. (0001810806) (Issuer)

    2/27/26 5:29:17 PM ET
    $U
    Computer Software: Prepackaged Software
    Technology

    $ABVC
    $ACXP
    $AFI
    $AFRM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 14, 2024 - FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

    For Immediate Release: November 14, 2024 The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients with aromatic L-amino acid decarboxylase (AADC) deficiency. Kebilidi is the first FDA-approved gene therapy for treatment of AADC deficiency. “Clinical advancements in the f

    11/14/24 8:50:18 AM ET
    $CLPT
    $PTCT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $ABVC
    $ACXP
    $AFI
    $AFRM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Carvana to Present at Upcoming Morgan Stanley Technology, Media & Telecom Conference

    Carvana (NYSE:CVNA), a leading e-commerce platform for buying and selling cars, today announced that Ernie Garcia, Carvana's Founder and Chief Executive Officer, will present to the investor community and host meetings at the upcoming Morgan Stanley Technology, Media & Telecom Conference. Morgan Stanley Technology, Media & Telecom Conference Presentation Date and Time: Monday, March 2, 2026, at 12:20 PM PT* *A webcast of the presentation will be accessible on the Investor Relations section of the Carvana website (https://investors.carvana.com). An archived replay of the webcast will be available following the live presentation. About Carvana Carvana's mission is to change the way pe

    2/27/26 8:00:00 AM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Bakkt Announces Pricing of $48.125 Million Registered Direct Offering

    NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Bakkt, Inc. ("Bakkt" or the "Company") (NYSE:BKKT) today announced the pricing of a registered direct offering of 3,024,799 shares of Class A common stock and pre-funded warrants to purchase up to 2,475,201 shares of Class A common stock at a price of $8.75 per share and $8.7499 per pre-funded warrant, which represents the per share price of each share of Class A common stock less the $0.0001 per share exercise price for each pre-funded warrant. The offering to a single institutional investor is expected to close on or around March 2, 2026, subject to customary closing conditions. The gross proceeds from the offering, before deducting placement a

    2/27/26 7:32:49 AM ET
    $BKKT
    Finance: Consumer Services
    Finance

    Docebo Reports Fourth Quarter and Fiscal Year 2025 Results

    Docebo Inc. (NASDAQ:DCBO, TSX:DCBO) ("Docebo" or the "Company"), a leading learning platform provider with a foundation in artificial intelligence (AI) and innovation, announced financial results for the three months and fiscal year ended December 31, 2025. All amounts are expressed in US dollars unless otherwise stated. "Q4 was one of Docebo's strongest quarters on record, with gross bookings performance being the strongest since 2021 and Adjusted EBITDA margins reaching 21.2%, both reflecting the compounding payoff of the AI-First strategy we've been executing against," said Alessio Artuffo, President and CEO of Docebo. "The caliber of enterprise customers who chose Docebo this quarter,

    2/27/26 6:00:00 AM ET
    $DCBO
    Computer Software: Prepackaged Software
    Technology

    $ABVC
    $ACXP
    $AFI
    $AFRM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on Enovix with a new price target

    TD Cowen reiterated coverage of Enovix with a rating of Hold and set a new price target of $7.50 from $15.00 previously

    2/26/26 6:56:07 AM ET
    $ENVX
    Industrial Machinery/Components
    Miscellaneous

    Robert W. Baird initiated coverage on Affirm with a new price target

    Robert W. Baird initiated coverage of Affirm with a rating of Neutral and set a new price target of $55.00

    2/20/26 8:23:24 AM ET
    $AFRM
    Finance: Consumer Services
    Finance

    Northland Capital initiated coverage on Fossil with a new price target

    Northland Capital initiated coverage of Fossil with a rating of Outperform and set a new price target of $7.00

    2/19/26 7:14:48 AM ET
    $FOSL
    Consumer Specialties
    Consumer Discretionary

    $ABVC
    $ACXP
    $AFI
    $AFRM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Derosa Thomas Joseph bought $6,754 worth of shares (20,000 units at $0.34), increasing direct ownership by 77% to 46,096 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    2/27/26 6:16:02 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    Director Lord Albert L bought $51,040 worth of shares (150,000 units at $0.34), increasing direct ownership by 5% to 3,170,394 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    2/26/26 5:35:56 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    Director Lord Albert L bought $1,665 worth of shares (4,200 units at $0.40), increasing direct ownership by 0.14% to 3,020,394 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    2/17/26 7:22:57 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    $ABVC
    $ACXP
    $AFI
    $AFRM
    Leadership Updates

    Live Leadership Updates

    View All

    Manulife Investment Management Announces Liam Spillane as Head of Emerging Markets Fixed Income

    LONDON, Feb. 26, 2026 /CNW/ - Manulife Investment Management ("Manulife IM") has announced the appointment of Liam Spillane as Head of Emerging Markets Fixed Income and Senior Portfolio Manager, Emerging Markets Debt. Based in London, Mr. Spillane joined the firm on January 26, 2026, and oversees its Emerging Markets Fixed Income organisation, managing a global team of portfolio managers and analysts. He holds responsibility for the growth of the firm's Emerging Markets Debt business and pursuit of strong investment performance across our range of strategies."I'm delighted to we

    2/26/26 7:30:00 AM ET
    $MFC
    Life Insurance
    Finance

    WorkWhile Names Simon Khalaf CEO as Company Enters Next Phase of Growth and Expands Into Worker Financial Services

    Co-Founder Jarah Euston transitions to President and COO; Platform surpasses 1.2 million workers SAN FRANCISCO, Feb. 25, 2026 /PRNewswire/ -- WorkWhile today announced a leadership transition as the company moves into its next phase of growth. Tech veteran and longtime board member Simon Khalaf has been named Chief Executive Officer. Co-Founder Jarah Euston will transition to President and Chief Operating Officer, where she will focus on scaling operations and accelerating expansion. The transition comes at a moment of strength for the company. WorkWhile now serves more than 1.2

    2/25/26 1:24:00 PM ET
    $MQ
    Computer Software: Prepackaged Software
    Technology

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    $ABVC
    $ACXP
    $AFI
    $AFRM
    Financials

    Live finance-specific insights

    View All

    Docebo Reports Fourth Quarter and Fiscal Year 2025 Results

    Docebo Inc. (NASDAQ:DCBO, TSX:DCBO) ("Docebo" or the "Company"), a leading learning platform provider with a foundation in artificial intelligence (AI) and innovation, announced financial results for the three months and fiscal year ended December 31, 2025. All amounts are expressed in US dollars unless otherwise stated. "Q4 was one of Docebo's strongest quarters on record, with gross bookings performance being the strongest since 2021 and Adjusted EBITDA margins reaching 21.2%, both reflecting the compounding payoff of the AI-First strategy we've been executing against," said Alessio Artuffo, President and CEO of Docebo. "The caliber of enterprise customers who chose Docebo this quarter,

    2/27/26 6:00:00 AM ET
    $DCBO
    Computer Software: Prepackaged Software
    Technology

    Coupang Announces Results for Fourth Quarter 2025

    Net Revenues of $8.8 billion, up 11% YoY and 14% on a constant currency basis Product Commerce Segment Adjusted EBITDA of $567 million, up $28 million YoY Developing Offerings Segment Net Revenues of $1.4 billion, up 32% YoY and 31% on a constant currency basis Coupang, Inc. (NYSE:CPNG) today announced financial results for its fourth quarter ended December 31, 2025. Q4 2025 Consolidated Highlights: Total net revenues were $8.8 billion, up 11% YoY on a reported basis and 14% YoY on a constant currency or FX-neutral basis. Gross profit increased 2% YoY and 5% YoY on a constant currency basis to $2.5 billion. Gross profit margin was 28.8%, a decrease of 248 bps YoY. Excluding it

    2/26/26 4:05:00 PM ET
    $CPNG
    Catalog/Specialty Distribution
    Consumer Discretionary

    Rockwell Medical to Release Fourth Quarter and Full-Year 2025 Results on Thursday, March 26, 2026

    Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the fourth quarter and full-year ended December 31, 2025 on Thursday, March 26, 2026. The Company will issue a press release at 6:00am ET followed by a live webcast at 8:00am ET. WEBCAST DETAILS Date: Thursday, March 26, 2026 Time: 8:00am ET Webcast and Replay: www.RockwellMed.com/Results Speakers: Mark Strobeck, Ph.D. — President and Chief Executive Officer Jesse Neri — SVP, Chief Financial Off

    2/26/26 6:00:00 AM ET
    $RMTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $ACXP
    $AFI
    $AFRM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEC Form SC 13G filed by DarioHealth Corp.

    SC 13G - DarioHealth Corp. (0001533998) (Subject)

    12/13/24 4:05:12 PM ET
    $DRIO
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/13/24 10:39:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary